Publication:
The effect of angilotensin-converting enzyme inhibitors on experimental colitis in rats

dc.contributor.authorERCAN, FERİHA
dc.contributor.authorsJahovic, N; Ercan, F; Gedik, N; Yuksel, M; Sener, G; Alican, I
dc.date.accessioned2022-03-12T17:20:29Z
dc.date.accessioned2026-01-11T19:19:37Z
dc.date.available2022-03-12T17:20:29Z
dc.date.issued2005
dc.description.abstractThe present study was aimed to investigate the effect of ACE inhibition on trinitrobenzene sulphonic acid (TNBS)-induced colonic inflammation in rats by using captopril and lisinopril. In treatment groups, the rats were treated with ACE inhibitors, captopril or lisinopril (0.1 and I mg/kg/day; intraperitoneally). The drugs were given 5 min after induction of colitis and the treatment was continued for 3 days. Three days after the induction of colitis, all rats were decapitated. The distal colon was weighed and the mucosal lesions were scored at both macroscopical at microscopic levels. Malondialdehyde (MDA) and glutathione (GSH) levels, myeloperoxidase (MPO) activity and collagen content were assessed in tissue samples. Formation of reactive oxygen species in colonic samples was monitored by using chemiluminescence technique. Serum TNF-alpha level was assessed in trunk blood. Captopril treatment was found to be beneficial in all parameters, except colonic glutathione content. On the other hand, although stimulation of lipid peroxidation and increase in serum TNF-a level were successfully prevented by lisinopril, the morphology of the lesions remained unchanged. In conclusion, sulphydryl and non-sulphydryl ACE inhibitors, captopril and lisinoptil do not seem to be similarly effective in TNBS-induced colitis model at least at the doses tested in our study. (c) 2005 Elsevier B.V. All rights reserved.
dc.identifier.doi10.1016/j.regpep.2005.03.009
dc.identifier.eissn1873-1686
dc.identifier.issn0167-0115
dc.identifier.pubmed15908024
dc.identifier.urihttps://hdl.handle.net/11424/228242
dc.identifier.wosWOS:000230973700010
dc.language.isoeng
dc.publisherELSEVIER SCIENCE BV
dc.relation.ispartofREGULATORY PEPTIDES
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectangiotensin-converting enzyme inhibitor
dc.subjectcaptopril
dc.subjectlisinopril
dc.subjectcolitis
dc.subjectrat
dc.subjectINFLAMMATORY BOWEL-DISEASE
dc.subjectTRINITROBENZENE SULFONIC-ACID
dc.subjectANGIOTENSIN-II
dc.subjectACE-INHIBITORS
dc.subjectREACTIVE OXYGEN
dc.subjectISCHEMIA-REPERFUSION
dc.subjectLIPID-PEROXIDATION
dc.subjectMETHYL-ESTER
dc.subjectNITRIC-OXIDE
dc.subjectL-ARGININE
dc.titleThe effect of angilotensin-converting enzyme inhibitors on experimental colitis in rats
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage74
oaire.citation.issue1-2
oaire.citation.startPage67
oaire.citation.titleREGULATORY PEPTIDES
oaire.citation.volume130

Files